Taysha Gene Therapies, Inc.
TSHA
5 insider filings · Latest: Jun 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 10, 2026 | Apr 13 4:33 PM | Sukumar NagendranDirector, President and Head of R&D | Sale | 200,000 | $4.46 | $892.0K | 1,136,410(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Jun 2 4:30 PM | John A Stalfort IIIDirector | Grant/Award | 42,671 | $5.97 | 42,671(D) | View → |
| Jun 1, 2026 | Jun 2 4:30 PM | Phillip B. DonenbergDirector | Grant/Award | 42,671 | $5.97 | 42,671(D) | View → |
| Jun 1, 2026 | Jun 2 4:30 PM | Alison S LongDirector | Grant/Award | 42,671 | $5.97 | 42,671(D) | View → |
| Jun 1, 2026 | Jun 2 4:30 PM | Laura Sepp-LorenzinoDirector | Grant/Award | 42,671 | $5.97 | 42,671(D) | View → |
| Apr 10, 2026 | Apr 13 4:33 PM | Sukumar NagendranDirector, President and Head of R&D | Option Exercise | 19,021 | $1.71 | 455,920(D) | View → |